<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Rui M</submitter><pubmed_abstract>The development of drug resistance in cancer cells is one of the major obstacles to achieving effective chemotherapy. We hypothesized that the combination of a doxorubicin (Dox) prodrug and microRNA (miR)21 inhibitor might show synergistic antitumor effects on drug-resistant breast cancer cells. In this study, we aimed to develop new high-density lipoprotein-mimicking nanoparticles (HMNs) for coencapsulation and codelivery of this potential combination. Dox was coupled with a nuclear localization signal (NLS) peptide to construct a prodrug (NLS-Dox), thereby electrostatically condensing miR21 inhibitor (anti-miR21) to form cationic complexes. The HMNs were formulated by shielding these complexes with anionic lipids and Apo AI proteins. We have characterized that the coloaded HMNs had unifo</pubmed_abstract><journal>International journal of nanomedicine</journal><pagination>217-237</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5221799</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.</pubmed_title><pmcid>PMC5221799</pmcid><pubmed_authors>Ge Y</pubmed_authors><pubmed_authors>Rui M</pubmed_authors><pubmed_authors>Qu Y</pubmed_authors><pubmed_authors>Xu X</pubmed_authors><pubmed_authors>Feng C</pubmed_authors><pubmed_authors>Gao T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Simultaneous delivery of anti-miR21 with doxorubicin prodrug by mimetic lipoprotein nanoparticles for synergistic effect against drug resistance in cancer cells.</name><description>The development of drug resistance in cancer cells is one of the major obstacles to achieving effective chemotherapy. We hypothesized that the combination of a doxorubicin (Dox) prodrug and microRNA (miR)21 inhibitor might show synergistic antitumor effects on drug-resistant breast cancer cells. In this study, we aimed to develop new high-density lipoprotein-mimicking nanoparticles (HMNs) for coencapsulation and codelivery of this potential combination. Dox was coupled with a nuclear localization signal (NLS) peptide to construct a prodrug (NLS-Dox), thereby electrostatically condensing miR21 inhibitor (anti-miR21) to form cationic complexes. The HMNs were formulated by shielding these complexes with anionic lipids and Apo AI proteins. We have characterized that the coloaded HMNs had unifo</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017</publication><modification>2025-04-26T13:43:02.528Z</modification><creation>2019-03-27T02:33:40Z</creation></dates><accession>S-EPMC5221799</accession><cross_references><pubmed>28115844</pubmed><doi>10.2147/IJN.S122171</doi></cross_references></HashMap>